Prestación de servicios de inmunización

Measles immunisation: time to close the gap

Since the beginning of the century, the number of measles-related deaths has fallen substantially; between 2000 and 2014 mass immunisation efforts prevented an estimated 17·1 million deaths worldwide, and the number of cases decreased from 146 to 40 per million. Unfortunately, after this decrease the situation has stagnated and many countries are falling far behind the 2015 elimination targets according to a report by WHO and the US Centers for Disease Control and Prevention (CDC) released in November, 2015.

Working Toward a World Where All Children are Safe from Measles and Rubella

Last week, the Board of Gavi, the Vaccine Alliance approved a measles and rubella strategy that will provide an additional $220 million to measles and rubella activities from 2016-2020. In total, Gavi will invest $820 million over the next five years on measles and rubella activities in Gavi-eligible countries.

México aprueba la primera vacuna contra el virus del dengue

México se convirtió este miércoles en el primer país en aprobar la primera vacuna contra el virus del dengue.

Así lo anunció la Secretaría de Salud a través de la Comisión Federal para la Protección contra Riesgos Sanitarios (Cofepris), que emitió el registro.La entidad aseguró en un comunicado que acreditó la calidad, seguridad y eficacia tras la realización de un ensayo con más de 40.000 personas en 15 países.


First Dengue Fever Vaccine Approved by Mexico

A dengue fever vaccine developed by the French pharmaceutical giant Sanofi has been approved for use by Mexico, the first approval in the world for any vaccine for the disease, which afflicts tens of millions of people around the world and is becoming an increasing threat.
Sanofi said in a news release Wednesday that the vaccine, which it is calling Dengvaxia, was approved by Mexico’s Federal Commission for the Protection against Sanitary Risk for prevention of dengue in people 9 to 45 years old living in endemic areas.

Sanofi wins first dengue vaccine market approval in Mexico

Sanofi's dengue vaccine is to make its market debut in Mexico, the French drugmaker said on Wednesday, adding that it expects to have filed for market approval in some 20 countries by year-end.
Sanofi Pasteur, the group's vaccines division, said Mexico had approved the preventive treatment, called Dengvaxia, for all four dengue virus serotypes, but only for patients aged 9 to 45 who live in areas where the disease is endemic.

Polio victory very close, Bill Gates says at UAE awards ceremony

The campaign to rid the world of polio is close to total success, Microsoft founder Bill Gates said at an awards ceremony in Abu Dhabi on Sunday night.
“It is close, very close. Now is the time to double down our efforts to eradicate this disease,” Mr Gates said at the event held to honour five heroes of the fight against the disease, who risk their lives for the cause.
“The donors have to step up for a couple of years more and the countries on the frontline will have to remain vigilant.”

Year in Review: Measles Linked to Disneyland

Measles in Disneyland
After an uncharacteristically high number of measles cases in late 2014, the highly publicized California measles outbreak hit the media early this year.  Linked to Disneyland Resort Theme Parks in California the outbreak quickly became a multi-state public health incident that resulted in a total of 147 cases. Cases related to this outbreak were identified in seven states in the U.S., as well as Mexico and Canada.

SUNY Upstate Medical University, U.S. Army start $12M partnership toward dengue vaccine

Sanofi ($SNY) is the furthest along in the race for a dengue vaccine, expecting to receive its first license to market its jab by the end of the year. But this doesn't mean others aren't trying to tackle the mosquito-borne disease. SUNY Upstate Medical University announced on Monday that it would partner with the U.S. Army on dengue studies that could help in the development of vaccines against the disease.

Cholera – Iraq

WHO received notification from the National IHR Focal Point of Iraq of additional laboratory-confirmed cases of cholera.

Cameroon: Measles/Rubella - Littoral: 1.2 Million Children for Vaccination

The vaccination campaign against measles and rubella kicked off in Government Bilingual Nursery and Primary School New-Bell Aviation Ngangue in the presence of the Governor of the Littoral Region, Samuel Dieudonné Ivaha Diboua. The vaccination campaign that targets some 1,260,000 children in the region between the ages of nine months and 14 years will be carried out from door to door by the numerous vaccination agents in 6 days.